Subtype
Ovarian Sertoli-Leydig Cell Tumor
CI-CAN-00008180Explore in graph →
Non-malignant1 active trials7 evidence items
Loading cancer entity…
Subtype
CI-CAN-00008180Explore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06638931 | Agnostic Therapy in Rare Solid Tumors(ANTARES) | recruiting | Phase 2 | 28 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Apr 15, 2026source: clinicaltrials